comparative valuations., page-3

DVEous---good posts but we are talking about 2 FDA trials that are funded by the US Dept of Defense--and more potential phase 3 trials to be announced for other applications that we all are aware of. Each of these pivotal trials should be worth a market cap of at least 100MM each in their own right at this late stage. And naturally if FDA approved we can all smile and guess where it will go. That is why the opportunity is now and not when the price goes up.

The US markets need a quality US brokerage to discover and write research and when that credibility piece comes the QX will become a lot more interesting. If you read through the tea leaves i must say with the good financial print medium write ups of a couple weeks back it may come sooner than you realize. When that happens the market cap will rise to where this really should be. It will not languish for months because i suspect you will soon see retail brokerage buying.